application for the treatment of skin diseases. These efforts culminated in the discovery of N‐(2,4‐dimethylphenyl)‐N‐isobutyl‐2‐oxo‐1‐[(tetrahydro‐2H‐pyran‐4‐yl)methyl]‐2,3‐dihydro‐1H‐benzo[d]imidazole‐5‐sulfonamide (CD12681), a potent inverse agonist with in vivo activity in an IL‐23‐induced mouse skin inflammation model.
视黄酸受体相关的孤儿受体RORγ可能对多种自身免疫性疾病有潜在影响,已成为制药行业的抢手目标。本文描述了鉴定与局部应用治疗皮肤疾病相容的有效RORγ反向激动剂的努力。这些努力最终导致发现了N-(2,4-二甲基苯基)-N-异丁基-2-氧代-1-[[(四氢-2 H-
吡喃-4-基)甲基] -2,3-二氢-1 H-苯并[ d ]
咪唑-5-磺酰胺(CD12681),一种有效的反向激动剂,在I
L-23诱导的小鼠皮肤炎症模型中具有体内活性。